Grillo Alessandra R, Starr Lisa R, Vrshek-Schallhorn Suzanne
Department of Psychology, University of North Carolina at Greensboro, Greensboro, North Carolina, USA.
Department of Psychology, University of Rochester, Rochester, New York, USA.
Stress Health. 2024 Dec;40(6):e3484. doi: 10.1002/smi.3484. Epub 2024 Oct 4.
Prior work consistently links additive genetic variation in the hypothalamic-pituitary-adrenal (HPA) axis-a multilocus genetic profile score (MGPS)-to depression risk in the context of stress exposure. However, despite that HPA MGPS variants were selected based on evidence that they elevate cortisol reactivity, there are surprisingly few tests of whether an HPA MGPS elevates cortisol reactivity to lab-based stress. Similarly, despite neurobiological connections and coordination between the HPA axis and the sympathetic nervous system (e.g., in the paraventricular nucleus and locus coeruleus), no work has tested whether an HPA MGPS influences sympathetic nervous system reactivity to stress. We investigated whether an HPA MGPS moderates the relation between lab-based stress and: (1) HPA activity indexed by cortisol, and/or (2) sympathetic activity indexed by salivary alpha-amylase, sAA. Emerging adults (N = 152; mean age = 19.5, largest subsample 44.4% Black/African American) were randomly assigned to one of two Trier Social Stress Test variations, a non-evaluative control, or an explicitly negative-evaluative condition. Participants provided DNA and repeated saliva samples for sAA and cortisol. The HPA MGPS did not significantly moderate the relationship between stress condition and cortisol or sAA reactivity, respectively; moreover, post-hoc tests highlight that individual polymorphisms showed non-significant effects in opposite directions from each other, cancelling out in aggregate. Findings suggest that the HPA MGPS's associations with cortisol reactivity are not as straightforward as initially believed. We speculate that the relationships of some HPA variants to biomarker reactivity may vary between modest lab-based stressors and the explicit negative-evaluative induction used here.
先前的研究一致将下丘脑-垂体-肾上腺(HPA)轴的加性遗传变异——一种多基因谱评分(MGPS)——与应激暴露情况下的抑郁风险联系起来。然而,尽管HPA MGPS变异是基于它们能提高皮质醇反应性的证据而选择的,但令人惊讶的是,很少有研究测试HPA MGPS是否会提高对实验室应激的皮质醇反应性。同样,尽管HPA轴与交感神经系统之间存在神经生物学联系和协调(例如,在室旁核和蓝斑),但尚无研究测试HPA MGPS是否会影响交感神经系统对应激的反应性。我们研究了HPA MGPS是否会调节基于实验室的应激与以下方面之间的关系:(1)以皮质醇为指标的HPA活性,和/或(2)以唾液α-淀粉酶(sAA)为指标的交感活性。将新兴成年人(N = 152;平均年龄 = 19.5岁,最大子样本为44.4%黑人/非裔美国人)随机分配到两种特里尔社会应激测试变体之一、非评估性对照或明确的负面评估条件中。参与者提供了DNA以及用于检测sAA和皮质醇的重复唾液样本。HPA MGPS并未分别显著调节应激条件与皮质醇或sAA反应性之间的关系;此外,事后检验表明,个体多态性显示出的非显著影响方向相反,总体上相互抵消。研究结果表明,HPA MGPS与皮质醇反应性之间的关联并不像最初认为的那样直接。我们推测,一些HPA变异与生物标志物反应性之间的关系可能在适度的基于实验室的应激源与此处使用的明确负面评估诱导之间有所不同。